These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1163576)

  • 21. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F; Guillebaud J
    Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fertility after discontinuation of levonorgestrel-releasing intrauterine devices.
    Nilsson CG
    Contraception; 1982 Mar; 25(3):273-8. PubMed ID: 6804163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian function in amenorrheic and menstruating users of a levonorgestrel-releasing intrauterine device.
    Nilsson CG; Lähteenmäki PL; Luukkainen T
    Fertil Steril; 1984 Jan; 41(1):52-5. PubMed ID: 6420203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma prolactin concentrations in women treated with low dose combination type oral contraceptives and in women using a d-norgestrel-releasing intrauterine device.
    Nilsson CG; Lähteenmäki P
    Ann Clin Res; 1978 Aug; 10(4):242-5. PubMed ID: 707973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma concentrations of levonorgestrel as a function of the release rate of levonorgestrel from medicated intra-uterine devices.
    Nilsson CG; Lähteenmäki P; Robertson DN; Luukkainen T
    Acta Endocrinol (Copenh); 1980 Mar; 93(3):380-4. PubMed ID: 7376797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of plasma concentrations of d-norgestrel during a one year follow-up in women with a d-norgestrel-releasing IUD.
    Nilsson CG; Luukkainen T; Lähteenmäki P
    Contraception; 1978 Jun; 17(6):569-73. PubMed ID: 720062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term intracervical contraception with a levonorgestrel device.
    El Mahgoub S
    Contraception; 1982 Apr; 25(4):357-74. PubMed ID: 6809421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
    Custo GM; Cosmi EV
    Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of U-coil progesterone releasing device versus inert U-coil IUD.
    Serour GI; Hamza A; El Sheikha Z; Hefnawi FI
    Popul Sci; 1982; (3):121-35. PubMed ID: 12266213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained intrauterine release of d-norgestrel.
    Luukkainen T; Nilsson CG
    Contraception; 1978 Oct; 18(4):451-4. PubMed ID: 720077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical performance of a levonorgestrel-releasing intracervical contraceptive device during the first two years of use.
    Ratsula K
    Contraception; 1989 Feb; 39(2):187-93. PubMed ID: 2495892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levonorgestrel-releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism?
    Mandelin E; Koistinen H; Koistinen R; Affandi B; Seppälä M
    Hum Reprod; 1997 Dec; 12(12):2671-5. PubMed ID: 9455833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women.
    Nilsson S; Nygren KG; Johansson ED
    Am J Obstet Gynecol; 1977 Sep; 129(2):178-84. PubMed ID: 900181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
    Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
    Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NORPLANT contraceptive implants advancing.
    Segal SJ
    Netw Res Triangle Park N C; 1984; 5(3):1-3. PubMed ID: 12279797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive overview of intrauterine contraceptive device (IUCD).
    Nnatu S
    J Obstet Gynaecol East Cent Africa; 1983 Sep; 2(3):91-6. PubMed ID: 12340192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical study of a progesterone-releasing intrauterine contraceptive device.
    Brenner PF; Cooper DL; Mishell DR
    Am J Obstet Gynecol; 1975 Mar; 121(5):704-6. PubMed ID: 1115173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative study on the clinical effects and endometrial findings of IUD].
    Chao CK
    Toho Igakkai Zasshi; 1988 Mar; 34(6):550-60. PubMed ID: 12343145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.